Daily non-political popular news in brief.

Progress toward an antitumor vaccine

A team led by Horst Kunst at the University of Mainz has found a way to bind a molecule that is typical for tumors to a carrier protein without irritating the immune system. As they report in the journal Angewandte Chemie, their method is based on an immunocompatible connection by way of a sulfur atom, namely, a thioether.

Read more »

Keywords: progress, toward, antitumor, vaccine

« Previous | Next »

Similar news on "Progress toward an antitumor vaccine":

1. Neutron probe yields break in superconductor mystery
   02-01-2007 · EurekAlert!
   U.S. and Canadian researchers report a major step toward solving a two-decades-old materials science mystery and progress toward the ultimate goal of engineering materials optimized for magnetic and electric properties.
   Similar news · Read more »
   
2. Secular, nationalist surge in Iraq continues, new survey shows
   09-06-2007 · EurekAlert!
   With the Bush Administration's progress report on Iraq due by Sept. 15, a new survey of nationally representative samples of the Iraqi population shows a continuation of two trends that give some reason for optimism about the future of that battle-scarred country: A continued shift away from political Islam among Sunnis and Kurds and a shift toward Iraqi nationalism among majority Shiites.
   Similar news · Read more »
   
3. Mouse model advances understanding of synovial sarcoma
   04-09-2007 · EurekAlert!
   A mouse model for synovial sarcoma has enabled scientists to make tremendous progress toward understanding the origin and pathogenesis of this highly aggressive soft-tissue malignancy. The research, published in the April issue of the journal Cancer Cell, published by Cell Press, provides new information about the timing and environment required for initiation and progression of synovial sarcoma. The mouse model is also likely to serve as an invaluable resource for development of successful therapeutic strategies for this often lethal cancer.
   Similar news · Read more »
   
4. MU research team makes progress toward 'printing' organs
   11-06-2007 · EurekAlert!
   For the past four years, Gabor Forgacs, the George H. Vineyard Professor of Physics in the MU College of Arts and Science, has been working to refine the process of "printing" tissue structures of complex shape with the aim of eventually building human organs. In the latest study, a research team led by Forgacs determined that the process of building such structures by printing does not harm the properties of the composing cells.
   Similar news · Read more »
   
5. Progress against sarcoma
   04-09-2007 · EurekAlert!
   University of Utah geneticists have engineered mice that can develop synovial sarcoma -- a significant early step toward developing new treatments for the aggressive, deadly cancer that most often kills teenagers and young adults. The genetically engineered, cancer-stricken mice were used to determine that synovial sarcoma develops in muscle cell precursors known as myoblasts, the researchers report in the April issue of the journal Cancer Cell.
   Similar news · Read more »
   
6. Progress toward new therapies for coronary artery disease
   11-07-2007 · EurekAlert!
   Coronary artery disease is a leading cause of mortality in Western countries. It cannot be cured. Recent research, led by Pilar Ruiz-Lozano, PhD, at the Burnham Institute for Medical Research, may lead to new therapies for coronary artery disease.
   Similar news · Read more »
   
7. Progress toward a targeted therapy for a specific form of leukemia
   04-15-2007 · EurekAlert!
   Leukemia strikes some 700 Belgians each year. Scientists are still searching for the cause of many forms of leukemia, including T cell acute lymphoblastic leukemia, or T-ALL. Now, VIB researchers connected to the Katholieke Universiteit Leuven have identified a new player in the development of some 10 percent of the T-ALL cases: MYB.
   Similar news · Read more »
   
8. Cancer vaccines -- Taking a jab at cancer by stimulating the immune system
   04-17-2007 · EurekAlert!
   As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.
   Similar news · Read more »
   
9. Progress toward artificial photosynthesis?
   03-12-2007 · EurekAlert!
   A team headed by M. Antonietti at the Max Planck Institute for Colloids and Interfaces has taken an important step toward artificial photosynthesis. As described in the journal Angewandte Chemie, they have activated CO2 for use in a chemical reaction by using graphitic carbon nitride as a catalyst.
   Similar news · Read more »
   
10. Quantum device traps, detects and manipulates the spin of single electrons
    09-27-2007 · EurekAlert!
    A novel device, developed by a team led by University at Buffalo engineers, simply and conveniently traps, detects and manipulates the single spin of an electron, overcoming some major obstacles that have prevented progress toward spintronics and spin-based quantum computing.
    Similar news · Read more »